Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia - PubMed (original) (raw)
Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia
Marco Tartaglia et al. Nat Genet. 2003 Jun.
Abstract
We report here that individuals with Noonan syndrome and juvenile myelomonocytic leukemia (JMML) have germline mutations in PTPN11 and that somatic mutations in PTPN11 account for 34% of non-syndromic JMML. Furthermore, we found mutations in PTPN11 in a small percentage of individuals with myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML). Functional analyses documented that the two most common mutations in PTPN11 associated with JMML caused a gain of function.
Similar articles
- Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia.
Bentires-Alj M, Paez JG, David FS, Keilhack H, Halmos B, Naoki K, Maris JM, Richardson A, Bardelli A, Sugarbaker DJ, Richards WG, Du J, Girard L, Minna JD, Loh ML, Fisher DE, Velculescu VE, Vogelstein B, Meyerson M, Sellers WR, Neel BG. Bentires-Alj M, et al. Cancer Res. 2004 Dec 15;64(24):8816-20. doi: 10.1158/0008-5472.CAN-04-1923. Cancer Res. 2004. PMID: 15604238 - Mutations of the PTPN11 and RAS genes in rhabdomyosarcoma and pediatric hematological malignancies.
Chen Y, Takita J, Hiwatari M, Igarashi T, Hanada R, Kikuchi A, Hongo T, Taki T, Ogasawara M, Shimada A, Hayashi Y. Chen Y, et al. Genes Chromosomes Cancer. 2006 Jun;45(6):583-91. doi: 10.1002/gcc.20322. Genes Chromosomes Cancer. 2006. PMID: 16518851 - Mutations of the PTPN11 gene in therapy-related MDS and AML with rare balanced chromosome translocations.
Christiansen DH, Desta F, Andersen MK, Pedersen-Bjergaard J. Christiansen DH, et al. Genes Chromosomes Cancer. 2007 Jun;46(6):517-21. doi: 10.1002/gcc.20426. Genes Chromosomes Cancer. 2007. PMID: 17330262 - Mutations of PTPN11 are rare in adult myeloid malignancies.
Hugues L, Cavé H, Philippe N, Pereira S, Fenaux P, Preudhomme C. Hugues L, et al. Haematologica. 2005 Jun;90(6):853-4. Haematologica. 2005. PMID: 15951301 Review. - PTPN11 mutations and genotype-phenotype correlations in Noonan and LEOPARD syndromes.
Ogata T, Yoshida R. Ogata T, et al. Pediatr Endocrinol Rev. 2005 Jun;2(4):669-74. Pediatr Endocrinol Rev. 2005. PMID: 16208280 Review.
Cited by
- Transient Myeloproliferative Disorder (TMD), Acute Lymphoblastic Leukemia (ALL), and Juvenile Myelomonocytic Leukemia (JMML) in a Child with Noonan Syndrome: Sequential Occurrence, Single Center Experience, and Review of the Literature.
Arrabito M, Li Volsi N, La Rosa M, Samperi P, Pulvirenti G, Cannata E, Russo G, Di Cataldo A, Lo Nigro L. Arrabito M, et al. Genes (Basel). 2024 Sep 10;15(9):1191. doi: 10.3390/genes15091191. Genes (Basel). 2024. PMID: 39336782 Free PMC article. Review. - Discovery of TK-642 as a highly potent, selective, orally bioavailable pyrazolopyrazine-based allosteric SHP2 inhibitor.
Tang K, Wang S, Feng S, Yang X, Guo Y, Ren X, Bai L, Yu B, Liu HM, Song Y. Tang K, et al. Acta Pharm Sin B. 2024 Aug;14(8):3624-3642. doi: 10.1016/j.apsb.2024.03.028. Epub 2024 Mar 26. Acta Pharm Sin B. 2024. PMID: 39234614 Free PMC article. - Prototypical innate immune mechanism hijacked by leukemia-initiating mutant stem cells for selective advantage and immune evasion in Ptpn11-associated juvenile myelomonocytic leukemia.
Zheng H, Zhao P, Tan Z, Yu WM, Werner J, Stieglitz E, Porter C, Chandrakasan S, Wechsler D, Mendez-Ferrer S, Qu CK. Zheng H, et al. Res Sq [Preprint]. 2024 Aug 2:rs.3.rs-4450642. doi: 10.21203/rs.3.rs-4450642/v1. Res Sq. 2024. PMID: 39149498 Free PMC article. Preprint. - The pathogenic T42A mutation in SHP2 rewires the interaction specificity of its N-terminal regulatory domain.
van Vlimmeren AE, Voleti R, Chartier CA, Jiang Z, Karandur D, Humphries PA, Lo WL, Shah NH. van Vlimmeren AE, et al. Proc Natl Acad Sci U S A. 2024 Jul 23;121(30):e2407159121. doi: 10.1073/pnas.2407159121. Epub 2024 Jul 16. Proc Natl Acad Sci U S A. 2024. PMID: 39012820 - SHP2 as a primordial epigenetic enzyme expunges histone H3 pTyr-54 to amend androgen receptor homeostasis.
Chouhan S, Sridaran D, Weimholt C, Luo J, Li T, Hodgson MC, Santos LN, Le Sommer S, Fang B, Koomen JM, Seeliger M, Qu CK, Yart A, Kontaridis MI, Mahajan K, Mahajan NP. Chouhan S, et al. Nat Commun. 2024 Jul 4;15(1):5629. doi: 10.1038/s41467-024-49978-4. Nat Commun. 2024. PMID: 38965223 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous